Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.44
+0.38 (1.89%)
Nov 24, 2025, 4:00 PM EST - Market closed

Neurogene Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
71.01136.59148.2182.0270.54
Short-Term Investments
194.41175.8248.95--
Cash & Short-Term Investments
265.41312.41197.1682.0270.54
Cash Growth
90.95%58.45%140.37%16.27%-
Other Receivables
0.860.650.60.990.79
Receivables
0.860.650.60.990.79
Prepaid Expenses
3.821.891.51.081.91
Other Current Assets
0.430.981.10.630.71
Total Current Assets
270.52315.92200.3584.7273.96
Property, Plant & Equipment
15.9118.4920.9524.5527.53
Other Long-Term Assets
1.41.311.27--
Total Assets
287.83335.73222.57109.27101.49
Accounts Payable
1.541.342.60.635.63
Accrued Expenses
9.19.3916.765.164.35
Current Portion of Leases
3.132.60.70.61
Other Current Liabilities
0.971.431.020.170.27
Total Current Liabilities
14.7115.1622.976.6510.86
Long-Term Leases
7.19.4312.373.994.6
Other Long-Term Liabilities
0.480.771.21--
Total Liabilities
22.2925.3636.5510.6415.46
Common Stock
----0
Additional Paid-In Capital
593.45572.67373.185.13.77
Retained Earnings
-327.91-262.3-187.15-150.84-95.65
Total Common Equity
265.54310.38186.02-145.74-91.88
Shareholders' Equity
265.54310.38186.0298.6386.03
Total Liabilities & Equity
287.83335.73222.57109.27101.49
Total Debt
10.2112.4314.974.695.21
Net Cash (Debt)
255.2299.98182.1977.3365.34
Net Cash Growth
102.74%64.65%135.59%18.36%-
Net Cash Per Share
12.3417.0839.12196.0116.13
Filing Date Shares Outstanding
15.4914.9312.855.674.05
Total Common Shares Outstanding
14.7814.8512.825.674.05
Working Capital
255.81300.77177.3878.0763.1
Book Value Per Share
17.9720.8914.51-25.72-22.68
Tangible Book Value
265.54310.38186.02-145.74-91.88
Tangible Book Value Per Share
17.9720.8914.51-25.72-22.68
Machinery
11.049.69.319.046.01
Construction In Progress
0.171.310.230.252.86
Leasehold Improvements
15.4215.415.3815.315.29
Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q